It has been demonstrated that CPT treatment significantly downregulated the GPER-mediated PI3K/AKT signaling pathway of the ERα-negative human breast cancer cells, SKBR-3, in a dose and time-dependent manner. The gene discussed is AKT1; the disease is breast cancer.